Skip to content

ACTonPainSCI - A randomised controlled pilot study to test the effectiveness of the online-based pain programme ACTonPain in people with paraplegia and chronic pain

ACTonPainSCI - A randomised controlled pilot study to test the effectiveness of the online-based pain programme ACTonPain in people with paraplegia and chronic pain - ACTonPainSCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031439
Enrollment
60
Registered
2023-03-21
Start date
2023-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain that has been present for at least 3 months and leads to severe impairments in everyday life. G82

Interventions

Group 1: Wartelistenkontrollgruppe: Teilnehmer erhalten nach einer Wartezeit (ca. 2,5 Monate) ebenfalls Zugriff auf das Online-Training 'PartnerCARE'. Sie durchlaufen das Training unbegleitet, d.h. oh

Sponsors

Klinik für psychosomatische Medizin und Psychotherapie, Universitätsklinikum Ulm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of spinal cord injury Presence of chronic pain (at least 3 months) Significant pain impairment (at least grade II according to the Chronic Pain Grade questionnaire (CPG; Korff et al. 1992) Medical requirements for participation in an internet-based pain program are given Sufficient knowledge of German Sufficient computer and internet skills Internet access available

Exclusion criteria

Exclusion criteria: Tumor-associated pain Ongoing or promptly planned outpatient psychotherapy or (partial) inpatient psychotherapy or inpatient treatment in a paraplegic center within the next three months.

Design outcomes

Primary

MeasureTime frame
3 measurement time points (self-report via questionnaires): Baseline measurement at time point T0 (before randomization), interim measurement at time point T1 (5 weeks after randomization), and the follow-up survey at time point T2 (10 weeks after randomization). Pain interference measured with the Pain Disability Index (PDI) as primary endpoint at T2 (after 10 weeks).

Secondary

MeasureTime frame
Pain intensity: Numerical rating scale Physical functioning: interference items of the BPI (Brief Pain Inventory) Emotional functioning: Patient Health Questionnaire (PHQ-8) & Generalized Anxiety Disorder (GAD-7) Life satisfaction: Satisfaction with Life Scale (SWLS) Quality of Life: WHOQOL-BREF Health-Related ACT-related outcome parameters Psychological flexibility: Questionnaire on Acceptance and Action II (FAH-II) Pain acceptance: German version of the Chronic Pain Acceptance Questionnaire (CPAQ-D) Committed Action (Behavioral Activation): Committed Action Questionnaire CAQ-G cognitive defusion: German version of the Cognitive Fusion Questionnaire CFQ-D Mindfulness: German version of the Five Facet Mindfulness Questionnaire (FFMQ-D)

Countries

Germany

Contacts

Public ContactKatja Reichert

Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Ulm

katja.reichert@uni-ulm.de0731/177-5111

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026